vimarsana.com

Page 3 - நிறுவன தகவல்கள் கிடங்கு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Q&A with Anil Bhasker, Cloud & Data platform Sales Leader, IBM Technology Sales

Q&A with Anil Bhasker, Cloud & Data platform Sales Leader, IBM Technology Sales June 01, 2021 Covid-19 has greatly accelerated the adoption of artificial intelligence in industries The pandemic has accelerated the rollout of AI in enterprises across industry verticals. In a conversation with BusinessLine, Anil Bhasker, Cloud & Data platform Sales Leader, IBM Technology Sales, IBM India/South Asia said, India is uniquely positioned to succeed in the AI economy. How has the pandemic impacted the adoption of AI in Indian enterprises? IBM’s Global AI Adoption Index 2021 found that while AI adoption was flat last year, we are poised for a major uptick in AI investments as companies continue to find ways to emerge from the pandemic. Many organizations in India lean on NLP (natural language processing) technologies and AI automation to help lower costs and get trusted information into the hands of their customers, partners and employees as they look for new ways to engage with them a

The different approaches to metadata management

May 18, 2021 Metadata management, the ability to provide context and meaning to data, is a foundation of many other data management disciplines. By Gary Allemann, MD of Master Data Management The broad range of applications for metadata mean that approaches to metadata management vary widely, with no one tool set or platform addressing every need – particularly when addressing the complex data landscapes of big, modern enterprises. A data catalogue is quickly becoming the cornerstone of metadata management for data-driven businesses. The catalogue is intended to ensure that any knowledge workers can quickly and easily find the data that they need to do their job, provide them with relevant context to allow them to make decisions, and get insight into how data is used within the organisation.

Clinical Trials Network brings nearly $7 million in contracts to UTHSC

 E-Mail Memphis, Tenn. (May 11, 2021) - The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical trial to test possible therapeutics for COVID-19 in hospitalized patients. This new trial brings the total generated by CTN2 contracts for the university to nearly $7 million. Since its launch in 2018, CTN2 has brought more than 200 clinical trial opportunities to the university and the citizens of Tennessee. Steven R. Goodman, PhD, vice chancellor for Research at UTHSC, who led the creation of CTN2, lauded the tremendous success of the nonprofit that enables clinical research faculty across all the UTHSC campuses, who are affiliated with hospitals, to effectively respond to opportunities for clinical trials with pharmaceutical, biotech, and medical device industry partners.

DATA ARCHITECT

5 Jun 2021 CARE is an international NGO with local staff and community partners in more than 90 countries. We create local solutions to poverty and inequality and we seek dignity for everyone every day and during times of crisis. These solutions have a broad range, from clean water to access to education; from microfinance to ensuring that everyone has nutritious food; from agriculture and climate change to disaster response. CARE puts women and girls at the center of everything we do because they have proven to be the best hope for creating lasting change in the world. Our staff live where they work, which makes us effective at understanding the challenges they face. We’ve been doing this for over 70 years, since World War II. It started with the world’s first CARE Package® of food for the post-war hungry in Europe. Our work today is as important as ever, we believe that poverty and inequality are historic injustices that we can end within a generation, for good. If you share

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.